Free Trial
→ Louis Navellier: My #1 AI stock for 2026 (name & ticker inside) (From InvestorPlace) (Ad)tc pixel Free URGN Stock Alerts
Live Earnings Conference Call: Urogen Pharma will host a live Q1 2026 earnings call on May 6, 2026 at 10:00AM ET. Follow this link to get details and listen to Urogen Pharma's Q1 2026 earnings call when it goes live. Get details.

Urogen Pharma (URGN) Earnings Date, Estimates & Call Transcripts

Urogen Pharma logo
$23.83 +0.54 (+2.32%)
Closing price 05/5/2026 04:00 PM Eastern
Extended Trading
$23.50 -0.32 (-1.36%)
As of 05/5/2026 06:07 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Urogen Pharma Earnings Summary

Urogen Pharma posted Q4 2025 earnings on March 2, 2026, reporting an EPS of -$0.54, which beat the consensus estimate of -$0.66 by $0.12. Quarterly revenue was reported to be $37.84 million, below the consensus estimate of $39.92 million. With a trailing EPS of -$3.20, Urogen Pharma's earnings are expected to grow next year, from ($1.45) to $0.79 per share.

Upcoming
Earnings Date
May. 6Estimated
Consensus EPS
(Mar. 2)
-$0.66
Actual EPS
(Mar. 2)
-$0.54 Beat By $0.12
Actual Revenue
(Mar. 2)
$37.84M

Q4 2025 Earnings Resources

URGN Upcoming Earnings

Urogen Pharma's Q1 2026 earnings is estimated for Wednesday, May 6, 2026, based on past reporting schedules, with a conference call scheduled at 10:00 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Q1 2026 Earnings Report
Powered by Quartr
Get Urogen Pharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Urogen Pharma and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

URGN Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

URGN Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Urogen Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20261-$0.60-$0.60-$0.60
Q2 20261-$0.64-$0.64-$0.64
Q3 20261-$0.42-$0.42-$0.42
Q4 20261-$0.33-$0.33-$0.33
FY 2026 4 -$1.99 -$1.99 -$1.99
Q1 20271-$0.28-$0.28-$0.28
Q2 20271-$0.04-$0.04-$0.04
Q3 20271$0.27$0.27$0.27
Q4 20271$0.51$0.51$0.51

Urogen Pharma Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
5/6/2026
(Estimated)		--$0.48-----
3/2/2026Q4 2025-$0.66-$0.54+$0.12-$0.54$39.92M$37.84M
11/6/2025Q3 2025-$0.72-$0.69+$0.03-$0.69$34.09M$27.48M
8/7/2025Q2 2025-$0.82-$1.05 -$0.23-$1.05$23.06M$24.22M
5/12/2025Q1 2025-$0.83-$0.92 -$0.09-$0.92$22.71M$20.25M
3/10/2025Q4 2024-$0.69-$0.80 -$0.11-$0.80$25.25M$24.57M
11/6/2024Q3 2024-$0.84-$0.55+$0.29-$0.55$24.22M$25.20M
8/13/2024Q2 2024-$0.82-$0.91 -$0.09-$0.91$23.69M$21.85M
5/13/2024Q1 2024-$0.93-$0.97 -$0.04-$0.97$20.73M$18.78M

Data powered by Fiscal.ai.

Urogen Pharma Earnings - Frequently Asked Questions

Urogen Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 6th, 2026 based off last year's report dates. Learn more on URGN's earnings history.

In the previous quarter, Urogen Pharma (NASDAQ:URGN) reported ($0.54) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.66) by $0.12. Learn more on analysts' earnings estimate vs. URGN's actual earnings.

The conference call for Urogen Pharma's latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Urogen Pharma's latest earnings report can be read online.
Read Transcript

Urogen Pharma (NASDAQ:URGN) has a recorded annual revenue of $109.79 million.

Urogen Pharma (NASDAQ:URGN) has a recorded net income of -$153.49 million. URGN has generated -$3.20 earnings per share over the last four quarters.

Urogen Pharma's earnings are expected to grow from ($1.45) per share to $0.79 per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:URGN) was last updated on 5/6/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
I’m sounding the alarm
Meta is cutting 10% of its workforce. Microsoft offered voluntary retirement to 7% of U.S. employees. Oracle, ...
Porter & Company | Sponsoredtc pixel
How to collect $1,170/month from silver
There is a silver fund paying up to 20% in yearly distributions - no mining stocks, no options required. The s...
Investors Alley | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Did you miss The Dark AI Summit?
Over 55,000 people attended Jeff Brown's Dark AI Summit, where he revealed a private AI company he believes ho...
Brownstone Research | Sponsoredtc pixel
"Computers are about to become obsolete" - George Gilder. Here’s why.
When the PC replaced the mainframe, companies that missed the shift went bankrupt. George Gilder - who called ...
Eagle Publishing | Sponsoredtc pixel
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next
Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The F...
Paradigm Press | Sponsoredtc pixel